Veröffentlichungen | Max Delbrück Center

179 Ergebnisse:

Active Filter:

Blankenstein, Thomas Prof. Dr.

14. März 2023 / J Immunother Cancer

Response to: Correspondence on 'H3.3K27M mutation is not a suitable target for immunotherapy in HLA-A2+ patients with diffuse midline glioma' by Chheda et al

L. Immisch
G. Papafotiou
O. Popp
P. Mertins
T. Blankenstein
G. Willimsky

01. März 2023 / Nat Immunol

IFNγ binding to extracellular matrix prevents fatal systemic toxicity

J. Kemna
E. Gout
L. Daniau
J. Lao
K. Weißert
S. Ammann
R. Kühn
M. Richter
C. Molenda
A. Sporbert
D. Zocholl
R. Klopfleisch
H. Lortat-Jacob
P. Aichele
T. Kammertoens
T. Blankenstein

16. Februar 2023 / Front Immunol

Targeting the recurrent Rac1P29S neoepitope in melanoma with heterologous high-affinity T cell receptors

L. Immisch
G. Papafotiou
N. Gallarín Delgado
V. Scheuplein
A. Paschen
T. Blankenstein
G. Willimsky

01. Februar 2023 / J Immunother Cancer

Generation of TGFβR2(-1) neoantigen-specific HLA-DR4-restricted T cell receptors for cancer therapy

N. Plewa
L. Poncette
T. Blankenstein

01. November 2022 / Cancer Immunol Res

Immune phenotypes and target antigens of clonally expanded bone marrow T cells in treatment-naïve multiple myeloma

C. Welters
M.F. Lammoglia Cobo
C.A. Stein
M.T. Hsu
A. Ben Hamza
L. Penter
X. Chen
C. Buccitelli
O. Popp
P. Mertins
K. Dietze
L. Bullinger
A. Moosmann
E. Blanc
D. Beule
A. Gerbitz
J. Strobel
H. Hackstein
H.P. Rahn
K. Dornmair
T. Blankenstein
L. Hansmann

27. Oktober 2022 / J Immunother Cancer

H3.3K27M mutation is not a suitable target for immunotherapy in HLA-A2(+) patients with diffuse midline glioma

L. Immisch
G. Papafotiou
O. Popp
P. Mertins
T. Blankenstein
G. Willimsky

01. August 2022 / Cytotherapy

Rapid single-cell identification of Epstein-Barr virus-specific T-cell receptors for cellular therapy

M.F. Lammoglia Cobo
C. Welters
L. Rosenberger
M. Leisegang
K. Dietze
C. Pircher
L. Penter
R. Gary
L. Bullinger
A. Takvorian
A. Moosmann
K. Dornmair
T. Blankenstein
T. Kammertöns
A. Gerbitz
L. Hansmann

08. Juni 2022 / Sci Adv

IFN-γ-dependent tumor-antigen cross-presentation by lymphatic endothelial cells promotes their killing by T cells and inhibits metastasis

L. Garnier
R. Pick
J. Montorfani
M. Sun
D. Brighouse
N. Liaudet
T. Kammertoens
T. Blankenstein
N. Page
J. Bernier-Latamani
N.L. Tran
T.V. Petrova
D. Merkler
C. Scheiermann
S. Hugues

06. April 2022 / Cancers

Isolation of neoantigen-specific human T cell receptors from different human and murine repertoires

C. Grunert
G. Willimsky
C.A. Peuker
S. Rhein
L. Hansmann
T. Blankenstein
E. Blanc
D. Beule
U. Keller
A. Pezzutto
A. Busse

01. Februar 2022 / Curr Opin Immunol

The role of CD4 T cells in rejection of solid tumors

L. Poncette
J. Bluhm
T. Blankenstein